Vegrandis Therapeutics Private Limited

Vegrandis Therapeutics Private Limited - research & development in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U73100TG2013PTC089739 Incorporated 29 August 2013 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company research and development
Revenue · FY 2017
₹8.82 Lakh
Latest filing
EBITDA · FY 2017
-₹8.51 Lakh
EBITDA margin -96.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Brands
1
Associated brands
Last financials
Mar 2018
Balance sheet date

About Vegrandis Therapeutics Private Limited

Data last updated:

Vegrandis Therapeutics Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 29 August 2013.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2013PTC089739.

The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Pushkar Kulkarni and Aarti Veeravalli Sevilimedu.

Its last annual general meeting (AGM) was held on 28 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Survey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046.

As per the financials filed for FY 2017, the company reported a revenue of ₹8.82 Lakh. For the same year it recorded EBITDA of -₹8.51 Lakh (EBITDA margin -96.5%).

The company was associated with 1 brand: Vegrandis Therapeutics.

Company details

CIN U73100TG2013PTC089739
Registration Number 089739
Incorporation Date 29 August 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Non-Compliant

CIN history

Vegrandis Therapeutics has one previous CIN (Corporate Identification Number): U73100AP2013PTC089739. The current CIN is U73100TG2013PTC089739, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U73100TG2013PTC089739Current
U73100AP2013PTC089739Previous

Contact details

Vegrandis Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Survey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046
  • Industry
    Research & Development, Research & Development

To see the full contact details of Vegrandis Therapeutics Private Limited, buy the company report.

Comprehensive company report
Vegrandis Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Vegrandis Therapeutics operates one associated brand: Vegrandis Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Limited information availablevegrandistherapeutics.com

Business activity

The main business activity of Vegrandis Therapeutics is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Vegrandis Therapeutics Private Limited, buy the company report.

Financials of Vegrandis Therapeutics Private Limited

FY 2018 filings available

Vegrandis Therapeutics Private Limited reported revenue of ₹8.82 Lakh for FY 2017.

Revenue · FY 2017
₹8.82 Lakh
EBITDA · FY 2017
-₹8.51 Lakh margin -96.5%

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹8.82 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹8.51 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin-96.5%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vegrandis Therapeutics Private Limited, buy the company report.

Board of directors of Vegrandis Therapeutics Private Limited

Vegrandis Therapeutics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Aarti Veeravalli SevilimeduAdditional Director13 May 201412 Years 6 MonthsAs last reported
Pushkar KulkarniDirector29 Aug 201313 Years 2 MonthsAs last reported

Auditor

Vegrandis Therapeutics Private Limited is audited by MP & Co for the financial year 2017.

Auditor firmFinancial yearFirm registration number
MP & CoFY 2017013406S

Shareholding

The shareholding of Vegrandis Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vegrandis Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vegrandis Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Vegrandis Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Vegrandis Therapeutics Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Srinivas Oruganti ceased to be Director on 30 Sep 2014.

AGM
Vegrandis Therapeutics Private Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records.
Filing
Vegrandis Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad.
Ceased
Srinivas Oruganti ceased to be Director.
Appointed
Aarti Veeravalli Sevilimedu was appointed as Additional Director.
Appointed
Pushkar Kulkarni was appointed as Director.
Incorporation
29 Aug 2013
Vegrandis Therapeutics Private Limited was registered on 29 Aug 2013 with Roc Hyderabad & aged 13 years 2 months as per MCA records.

Frequently asked questions

Vegrandis Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Vegrandis Therapeutics was a private limited company based in Hyderabad, Telangana, India. The company worked in the research and development industry. It was incorporated on 29 August 2013 and is registered under CIN U73100TG2013PTC089739. The company has been struck off by the Registrar of Companies and is no longer operational.

Vegrandis Therapeutics had 2 directors:

The CIN (Corporate Identification Number) of Vegrandis Therapeutics is U73100TG2013PTC089739. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Vegrandis Therapeutics is at Survey No. 25 Part – 1 – 9 Ils Building University Of Hyderabad Campus Gachibow, Li, Telangana, India – 500046.

Vegrandis Therapeutics was incorporated on 29 August 2013. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of Vegrandis Therapeutics on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 28 September 2018. Year-wise statements from 2015 are in the company report.

Vegrandis Therapeutics operated in the research and development industry. It worked in this industry before it was struck off.

Srinivas Oruganti ceased to be Director on 30 Sep 2014. Aarti Veeravalli Sevilimedu was appointed as Additional Director on 13 May 2014. Pushkar Kulkarni was appointed as Director on 29 Aug 2013.

The compliance status of Vegrandis Therapeutics is active non-compliant as of 25 July 2026.